UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2023

Commission File Number: 001-40488

Molecular Partners AG
(Translation of registrant's name into English)

Wagistrasse 14
8952 Zurich-Schlieren
Switzerland
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
99.1   Condensed consolidated interim financial statements (unaudited)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

        Molecular Partners AG    
    (Registrant)
     
   
Date: May 12, 2023       /s/ PATRICK AMSTUTZ    
    Patrick Amstutz
    Chief Executive Officer
   
Molecular Partners (PK) (USOTC:MLLCF)
過去 株価チャート
から 1 2025 まで 2 2025 Molecular Partners (PK)のチャートをもっと見るにはこちらをクリック
Molecular Partners (PK) (USOTC:MLLCF)
過去 株価チャート
から 2 2024 まで 2 2025 Molecular Partners (PK)のチャートをもっと見るにはこちらをクリック